You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aurora A inhibitor

Showing 1 - 25 of 7,943
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung

Recruiting
  • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Liver Cancer, Hepatocellular Carcinoma, Resistant Cancer Trial in Shanghai (Lenvatinib Oral Product Plus VIC1911)

Not yet recruiting
  • Liver Cancer
  • +2 more
  • Lenvatinib Oral Product Plus VIC1911
  • Shanghai, China
    Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine,
Jan 30, 2023

Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

Not yet recruiting
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Amivantamab 1050mg
  • +2 more
  • Aurora, Colorado
  • +2 more
Apr 25, 2023

Metastatic Breast Cancer, Solid Tumors Trial in Aurora (Alisertib, MLN0128)

Completed
Has Results
  • Metastatic Breast Cancer
  • Solid Tumors
  • Aurora, Colorado
    University of Colorado Cancer Center
May 17, 2022

Solid Tumors Trial in Buffalo, San Antonio (CYC116)

Terminated
  • Solid Tumors
  • Buffalo, New York
  • +1 more
Dec 7, 2021

NSCLC Trial in United States (VIC-1911, sotorasib)

Recruiting
  • Non-small Cell Lung Cancer
  • Sacramento, California
  • +4 more
Jan 5, 2023

Eosinophilic Esophagitis Trial in Aurora (Omeprazole 20mg BID)

Recruiting
  • Eosinophilic Esophagitis
  • Omeprazole 20mg BID
  • Aurora, Colorado
    Children's Hospital Colorado
Jul 28, 2022

Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC Trial (JAB-2485 (Aurora A inhibitor))

Not yet recruiting
  • Solid Tumors
  • +4 more
  • JAB-2485 (Aurora A inhibitor)
  • (no location specified)
Aug 4, 2022

COPD, Pulmonary Hypertension, Dyspnea Trial in United States (Tadalafil, Placebo)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • +2 more
  • Aurora, Colorado
  • +4 more
Jul 14, 2023

Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal

Recruiting
  • Platinum-Refractory Fallopian Tube Carcinoma
  • +11 more
  • Copanlisib Hydrochloride
  • +4 more
  • Aurora, Colorado
  • +2 more
Dec 8, 2022

Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Malignant Solid Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Non Small Cell Lung Cancer, KRAS Activating Mutation, Advanced Cancer Trial in United States (VS-6766 and adagrasib)

Recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • avutometinib (VS-6766) and adagrasib
  • San Francisco, California
  • +4 more
Dec 21, 2022

Adult Solid Tumor Trial in Scottsdale, Aurora, Nashville (SQZ-eAPC-HPV, Pembrolizumab)

Recruiting
  • Adult Solid Tumor
  • SQZ-eAPC-HPV
  • Pembrolizumab
  • Scottsdale, Arizona
  • +4 more
Jan 26, 2023

Non Small Cell Lung Cancer, NSCLC, NSCLC Trial in Australia, Korea, Republic of, United States (TPX-0131)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • Orange, California
  • +13 more
Nov 7, 2022

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Completed
  • Hemophilia
  • +7 more
    • Phoenix, Arizona
    • +26 more
    Jan 30, 2023

    Amyotrophic Lateral Sclerosis Trial in Australia, United States (Fasudil (WP-0512))

    Recruiting
    • Amyotrophic Lateral Sclerosis
    • Fasudil (WP-0512)
    • Phoenix, Arizona
    • +11 more
    Oct 28, 2022

    Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)

    Completed
    Has Results
    • Adult Acute Myeloid Leukemia in Remission
    • Recurrent Adult Acute Myeloid Leukemia
    • Aurora, Colorado
    • +1 more
    Dec 30, 2021

    Hematologic Malignancies Trial in Worldwide (Itacitinib, Calcineurin inhibitor)

    Terminated
    • Hematologic Malignancies
    • Aurora, Colorado
    • +16 more
    Apr 29, 2022

    Solid Tumor, Adult Trial in Spain, United States (RBN-2397)

    Recruiting
    • Solid Tumor, Adult
    • Aurora, Colorado
    • +14 more
    Jul 5, 2022

    GVHD, Malignancy Trial in Canada, United States (Abatacept, )

    Active, not recruiting
    Has Results
    • Graft vs Host Disease
    • Malignancy
    • Los Angeles, California
    • +13 more
    Jan 9, 2023

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7

    Active, not recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Duarte, California
    • +14 more
    Jan 27, 2023

    LMNA-Related Dilated Cardiomyopathy Trial in United States (ARRY-371797, p38 inhibitor, oral)

    Completed
    Has Results
    • LMNA-Related Dilated Cardiomyopathy
    • ARRY-371797, p38 inhibitor, oral
    • Aurora, Colorado
    • +3 more
    Mar 3, 2022

    Classic Galactosemia Trial in Aurora, Atlanta, Ann Arbor (AT-007, Placebo)

    Active, not recruiting
    • Classic Galactosemia
    • Aurora, Colorado
    • +2 more
    Feb 16, 2022

    Solid Tumors, NHL Trial in Canada, United States (KPT-9274, Niacin ER, Nivolumab)

    Terminated
    • Solid Tumors
    • NHL
    • Los Angeles, California
    • +7 more
    Jan 18, 2023

    Relapsed/Refractory Multiple Myeloma, Relapsed/Refractory DLBCL Trial in United States (EZM0414)

    Recruiting
    • Relapsed/Refractory Multiple Myeloma
    • Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    • Chevy Chase, Maryland
    • +10 more
    Jan 12, 2023